Cargando…
Expression of RAD51 and Its Clinical Impact in Oral Squamous Cell Carcinoma
PURPOSE: To examine the expression of RAD51 in oral squamous cell carcinoma (OSCC) and analyze its connection with pathological grade, clinical stage, and lymphatic metastasis potential. METHODS: For this study, 74 OSCC samples, 15 normal mucosa tissues, and 11 normal skin tissue samples were collec...
Autores principales: | Li, Yuyang, Li, Jia, Sun, Jingchun, Liu, Yingkun, Liu, Dingkun, Du, Liuyi, Wang, Bizhou, Liu, Weiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072096/ https://www.ncbi.nlm.nih.gov/pubmed/32190537 http://dx.doi.org/10.1155/2020/1827676 |
Ejemplares similares
-
Rad51 paralogs Rad55-Rad57 balance the anti-recombinase Srs2 in Rad51 filament formation
por: Liu, Jie, et al.
Publicado: (2011) -
RAD51 is a poor prognostic marker and a potential therapeutic target for oral squamous cell carcinoma
por: Tsai, Yu-Fen, et al.
Publicado: (2023) -
Roles of XRCC2, RAD51B and RAD51D in RAD51-Independent SSA Recombination
por: Serra, Heïdi, et al.
Publicado: (2013) -
Structure and function of the RAD51B-RAD51C-RAD51D-XRCC2 tumour suppressor
por: Greenhough, Luke A., et al.
Publicado: (2023) -
Identification of Nanog as a novel inhibitor of Rad51
por: Xin, Ying, et al.
Publicado: (2022)